Horizon Therapeutics: Q4 Earnings Insights

Horizon Therapeutics HZNP reported its Q4 earnings results on Tuesday, March 1, 2022 at 07:00 AM.

Here's what investors need to know about the announcement.

Horizon Therapeutics beat estimated earnings by 5.22%, reporting an EPS of $1.41 versus an estimate of $1.34.

Revenue was up $268.69 million from the same period last year.

Last quarter the company beat on EPS by $0.21 which was followed by a 4.58% drop in the share price the next day.

Here's a look at Horizon Therapeutics's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	1.54	0.88	0.04	1.05
EPS Actual	1.75	1.62	0.03	1.28
Revenue Estimate	979.41M	685.03M	330.73M	690.03M
Revenue Actual	1.04B	832.55M	342.41M	745.31M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.